{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+II&page=35", "query": { "intervention": "Control II", "page": 35 }, "page_size": 10 }, "pagination": { "page": 35, "page_size": 10, "total_count": 2665, "total_pages": 267, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+II&page=36&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+II&page=34&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T21:10:26.352Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00027963", "title": "Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neurotoxicity", "Pain" ], "interventions": [ { "name": "gabapentin", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2002-02", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2016-07-04", "last_synced_at": "2026-10-25T21:10:26.352Z", "location_count": 22, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Peoria, Illinois + 19 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Urbana", "state": "Illinois" }, { "city": "Cedar Rapids", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT00027963" }, { "nct_id": "NCT00194116", "title": "Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Divalproex Sodium ER", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University Hospitals Cleveland Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "16 Years to 65 Years" }, "enrollment_count": 54, "start_date": "2004-09", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2019-07-17", "last_synced_at": "2026-10-25T21:10:26.352Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00194116" }, { "nct_id": "NCT00002804", "title": "Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoma" ], "interventions": [ { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "ifosfamide", "type": "DRUG" }, { "name": "mesna", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "brachytherapy", "type": "RADIATION" }, { "name": "low-LET cobalt-60 gamma ray therapy", "type": "RADIATION" }, { "name": "low-LET electron therapy", "type": "RADIATION" }, { "name": "low-LET photon therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 43, "start_date": "1996-09", "completion_date": "2006-04", "has_results": false, "last_update_posted_date": "2014-07-25", "last_synced_at": "2026-10-25T21:10:26.352Z", "location_count": 7, "location_summary": "Wichita, Kansas • New Orleans, Louisiana • Memphis, Tennessee + 4 more", "locations": [ { "city": "Wichita", "state": "Kansas" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Memphis", "state": "Tennessee" }, { "city": "Dallas", "state": "Texas" }, { "city": "Lackland Air Force Base", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002804" }, { "nct_id": "NCT00540618", "title": "A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "MEDI-507", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 420, "start_date": "2001-09", "completion_date": "2003-07", "has_results": false, "last_update_posted_date": "2007-11-28", "last_synced_at": "2026-10-25T21:10:26.352Z", "location_count": 36, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Fresno, California + 29 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Vallejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00540618" }, { "nct_id": "NCT01790113", "title": "Arthrex Eclipse™ Shoulder Prosthesis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis" ], "interventions": [ { "name": "Univers™", "type": "DEVICE" }, { "name": "Eclipse™ Total Shoulder Replacement", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Arthrex, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 303, "start_date": "2013-02-04", "completion_date": "2019-06-07", "has_results": true, "last_update_posted_date": "2021-02-03", "last_synced_at": "2026-10-25T21:10:26.352Z", "location_count": 16, "location_summary": "Sun City, Arizona • Redwood City, California • Denver, Colorado + 13 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Redwood City", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01790113" }, { "nct_id": "NCT07489885", "title": "A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "D-2570 Tablet", "type": "DRUG" }, { "name": "Placebo Tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "InventisBio Co., Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 75, "start_date": "2026-06-03", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-10-25T21:10:26.352Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Chula Vista, California + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fremont", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07489885" }, { "nct_id": "NCT07858435", "title": "Intra-ovarian CAPA-IVM vs Standard IVM", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Infertility (IVF Patients)", "Infertility", "Infertility Female" ], "interventions": [ { "name": "CAPA-IVM", "type": "PROCEDURE" }, { "name": "In-House CAPA-IVM Pre-Maturation Medium", "type": "DEVICE" }, { "name": "Minimal-Stimulation OS-IVF", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DEVICE" ], "sponsor": "New Hope Fertility Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "38 Years", "sex": "FEMALE", "summary": "18 Years to 38 Years · Female only" }, "enrollment_count": 20, "start_date": "2026-10", "completion_date": "2027-10", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-25T21:10:26.352Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07858435" }, { "nct_id": "NCT07398508", "title": "NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Menkes Disease" ], "interventions": [ { "name": "Droxidopa Oral Product", "type": "DRUG" }, { "name": "Placebo Control", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Stephen G. Kaler", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "7 Years to 17 Years" }, "enrollment_count": 6, "start_date": "2026-08-10", "completion_date": "2030-06-30", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-25T21:10:26.352Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07398508" }, { "nct_id": "NCT02547935", "title": "A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus, CKD and Albuminuria" ], "interventions": [ { "name": "Dapagliflozin 10 mg", "type": "DRUG" }, { "name": "Saxagliptin 2.5 mg", "type": "DRUG" }, { "name": "Matching Placebo for Dapagliflozin 10 mg and Saxagliptin 2.5mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 459, "start_date": "2015-09-21", "completion_date": "2018-05-18", "has_results": true, "last_update_posted_date": "2019-08-21", "last_synced_at": "2026-10-25T21:10:26.352Z", "location_count": 37, "location_summary": "Peoria, Arizona • Chula Vista, California • Concord, California + 34 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Concord", "state": "California" }, { "city": "El Centro", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02547935" }, { "nct_id": "NCT02287038", "title": "Atomoxetine in Veterans With Comorbid ADHD/PTSD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Post Traumatic Stress Disorder", "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "Atomoxetine 80 MG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "20 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "20 Years to 60 Years" }, "enrollment_count": 44, "start_date": "2014-10-15", "completion_date": "2017-04-14", "has_results": true, "last_update_posted_date": "2019-04-03", "last_synced_at": "2026-10-25T21:10:26.352Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02287038" } ] }